Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
COVID has opened up potentially lucrative opportunities for these Aussie microcaps
News
CSL in $1.7bn deal to make two COVID-19 vaccines for Aussies
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Health & Biotech
University of Queensland’s COVID-19 vaccine becomes 32nd globally to head into human trials
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
Experts
Scopo’s health powerplays: Health goes up when markets go down
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Experts
Scopo’s health powerplays: Get ready for the pullback
Health & Biotech
Large caps deny they’re being outgunned by smaller peers in health R&D
Health & Biotech
We’re still here: investors keen on health despite market shun
Experts
Scopo’s health powerplays: Markets be crazy, buy the dip
Health & Biotech
COVID-19 treatments are a better bet than a vaccine
Experts
ScoPo’s health powerplays: How to invest in COVID-19
Health & Biotech
